Financial Performance - Sabra Healthcare reported quarterly funds from operations (FFO) of $0.38 per share, exceeding the Zacks Consensus Estimate of $0.37 per share, and up from $0.36 per share a year ago, representing an FFO surprise of +2.70% [1] - The company posted revenues of $189.15 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 1.98%, compared to year-ago revenues of $176.14 million [2] Market Performance - Sabra shares have increased approximately 5.6% since the beginning of the year, while the S&P 500 has gained 6.1% [3] - The current consensus FFO estimate for the upcoming quarter is $0.38 on revenues of $188.99 million, and for the current fiscal year, it is $1.49 on revenues of $749.82 million [7] Industry Outlook - The REIT and Equity Trust - Other industry, to which Sabra belongs, is currently ranked in the top 38% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in estimate revisions, which can impact Sabra's stock performance [5]